Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women

Clinical Endocrinology

Volumn 67, Issue 1, 2007, Pages 152-158

  Kim, Beom Jun ^a   Yu, Yong Mi ^a   Kim, Euy Nyong ^a   Chung, Yun Ey ^b   Koh, Jung Min ^a   Kim, Ghi Su ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul Veterans Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; C REACTIVE PROTEIN; COLLAGEN TYPE 1; MARKER;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; BODY MASS; BONE TURNOVER; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK FACTOR; TURBIDIMETRY; TURNOVER TIME;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; C-REACTIVE PROTEIN; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; POSTMENOPAUSE; RISK; STATISTICS, NONPARAMETRIC;

EID: 34250741955     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02853.x     Document Type: Article

References (38)

1. Kado, D.M., Browner, W.S., Blackwell, T., Gore, R. Cummings, S.R. (2000) Rate of bone loss is associated with mortality in older women: a prospective study. Journal of Bone Mineral Research, 15, 1974 1980.
2. von der Recke, P., Hansen, M.A. Hassager, C. (1999) The association between low bone mass at the menopause and cardiovascular mortality. American Journal of Medicine, 106, 273 278.
3. Tanko, L.B., Christiansen, C., Cox, D.A., Geiger, M.J., McNabb, M.A. Cummings, S.R. (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. Journal of Bone Mineral Research, 20, 1912 1920.
4. Hak, A.E., Pols, H.A., van Hemert, A.M., Hofman, A. Witteman, J.C. (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 1926 1931.
5. Price, P.A., Faus, S.A. Williamson, M.K. (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 817 824.
6. McFarlane, S.I., Muniyappa, R., Shin, J.J., Bahtiyar, G. Sowers, J.R. (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine, 23, 1 10.
7. Parhami, F., Morrow, A.D., Balucan, J., Leitinger, N., Watson, A.D., Tintut, Y., Berliner, J.A. Demer, L.L. (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 680 687.
8. Armour, K.E., Armour, K.J., Gallagher, M.E., Godecke, A., Helfrich, M.H., Reid, D.M. Ralston, S.H. (2001) Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology, 142, 760 766.
9. Kuhlencordt, P.J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T.H., Hajjar, R., Picard, M.H. Huang, P.L. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation, 104, 448 454.
10. Taylor, B.C., Schreiner, P.J., Doherty, T.M., Fornage, M., Carr, J.J. Sidney, S. (2005) Matrix Gla protein and osteopontin genetic associations with coronary artery calcification and bone density: the CARDIA study. Human Genetics, 116, 525 528.
11. Hofbauer, L.C. Schoppet, M. (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet, 358, 257 259.
12. Kontogianni, M.D., Dafni, U.G., Routsias, J.G. Skopouli, F.N. (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Journal of Bone Mineral Research, 19, 546 551.
13. Ross, R. (1999) Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 340, 115 126.
14. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. Hennekens, C.H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973 979.
15. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. Cook, N.R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 1557 1565.
16. Ridker, P.M., Hennekens, C.H., Buring, J.E. Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836 843.
17. Whitcomb, B.W., Bruder, J.M., Bauer, R.L., Mahaney, M.C., Tracy, R.P., Kammerer, C.M. Mitchell, B.D. (2004) C-reactive protein levels are associated with decreased bone mineral density in Mexican Americans (Abstract). Journal of Bone and Mineral Research, S289.
18. Koh, J.M., Khang, Y.H., Jung, C.H., Bae, S., Kim, D.J., Chung, Y.E. Kim, G.S. (2005) Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporosis International, 16, 1263 1271.
19. Parfitt, A.M. (1994) Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. Journal of Cell Biochemistry, 55, 273 286.
20. Manolagas, S.C. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews, 21, 115 137.
21. Gardsell, P., Johnell, O. Nilsson, B.E. (1991) The predictive value of bone loss for fragility fractures in women: a longitudinal study over 15 years. Calcified Tissue International, 49, 90 94.
22. Garnero, P., Hausherr, E., Chapuy, M.C., Marcelli, C., Grandjean, H., Muller, C., Cormier, C., Breart, G., Meunier, P.J. Delmas, P.D. (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Journal of Bone and Mineral Research, 11, 1531 1538.
23. Yeh, E.T. Willerson, J.T. (2003) Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation, 107, 370 371.
24. Chang, J.W., Yang, W.S., Min, W.K., Lee, S.K., Park, J.S. Kim, S.B. (2002) Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. American Journal of Kidney Disease, 39, 1213 1217.
25. Roodman, G.D. (1992) Interleukin-6: an osteotropic factor? Journal of Bone Mineral Research, 7, 475 478.
26. Jilka, R.L., Hangoc, G., Girasole, G., Passeri, G., Williams, D.C., Abrams, J.S., Boyce, B., Broxmeyer, H. Manolagas, S.C. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science, 257, 88 91.
27. Roodman, G.D., Kurihara, N., Ohsaki, Y., Kukita, A., Hosking, D., Demulder, A., Smith, J.F. Singer, F.R. (1992) Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. Journal of Clinical Investigations, 89, 46 52.
28. Willerson, J.T. Ridker, P.M. (2004) Inflammation as a cardiovascular risk factor. Circulation, 109, II2 II10.
29. Teitelbaum, S.L. (2004) RANKing c-Jun in osteoclast development. Journal of Clinical Investigations, 114, 463 465.
30. Collins, T. Cybulsky, M.I. (2001) NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? Journal of Clinical Investigations, 107, 255 264.
31. Liang, Y.J., Shyu, K.G., Wang, B.W. Lai, L.P. (2006) C-reactive protein activates the nuclear factor-kappaB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. Journal of Molecular Cell Cardiology, 40, 412 420.
32. Cottone, S., Mule, G., Nardi, E., Vadala, A., Guarneri, M., Briolotta, C., Arsena, R., Palermo, A., Riccobene, R. Cerasola, G. (2006) Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. American Journal of Hypertension, 19, 313 318.
33. Stephens, J.M., Butts, M.D. Pekala, P.H. (1992) Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumor necrosis factor-alpha. Journal of Molecular Endocrinology, 9, 61 72.
34. Weitzmann, M.N. Pacifici, R. (2005) The role of T lymphocytes in bone metabolism. Immunological Review, 208, 154 168.
35. Arenas, I.A., Armstrong, S.J., Xu, Y. Davidge, S.T. (2006) Tumor necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats. Hypertension, 48, 497 503.
36. Sinnott, B., Syed, I., Sevrukov, A. Barengolts, E. (2006) Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcified Tissue International, 78, 195 202.
37. Nordin, B.E., JM, W.I., Clifton, P.M., McArthur, R., Scopacasa, F., Need, A.G., Morris, H.A., O'Loughlin, P.D. Horowitz, M. (2004) A longitudinal study of bone-related biochemical changes at the menopause. Clinical Endocrinology, 61, 123 130.
38. Nordin, B.E., Need, A.G., Morris, H.A. Horowitz, M. (1999) Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporosis International, 9, 351 357.